TF and deep vein thrombosis: These results further verified the efficacy of the active ingredients in the treatment of thrombosis might be due to interaction with these core targets, and one mechanism of CX in the treatment of thrombosis might be that the active compounds bind to the TF target and decrease the procoagulant activity of TF, thus inhibiting thrombus formation.